This report contains market size and forecasts of Angina Pectoris Drugs in Global, including the following market information:
Global Angina Pectoris Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Angina Pectoris Drugs market was valued at 8865.7 million in 2020 and is projected to reach US$ 10860 million by 2027, at a CAGR of 5.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angina Pectoris Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angina Pectoris Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Angina Pectoris Drugs Market Segment Percentages, By Type, 2020 (%)
Beta Blockers
Calcium Antagonists
Anticoagulants
Anti-Platelets
Others
China Angina Pectoris Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Angina Pectoris Drugs Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
ASCs
Global Angina Pectoris Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Angina Pectoris Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Angina Pectoris Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Angina Pectoris Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer
Bayer
AstraZeneca
Gilead
Novartis
GlaxoSmithKline
Merck
Mylan
Teva Pharmaceutical
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Angina Pectoris Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angina Pectoris Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Angina Pectoris Drugs Overall Market Size
2.1 Global Angina Pectoris Drugs Market Size: 2021 VS 2027
2.2 Global Angina Pectoris Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Angina Pectoris Drugs Players in Global Market
3.2 Top Global Angina Pectoris Drugs Companies Ranked by Revenue
3.3 Global Angina Pectoris Drugs Revenue by Companies
3.4 Top 3 and Top 5 Angina Pectoris Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Angina Pectoris Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Angina Pectoris Drugs Players in Global Market
3.6.1 List of Global Tier 1 Angina Pectoris Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Angina Pectoris Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Angina Pectoris Drugs Market Size Markets, 2021 & 2027
4.1.2 Beta Blockers
4.1.3 Calcium Antagonists
4.1.4 Anticoagulants
4.1.5 Anti-Platelets
4.1.6 Others
4.2 By Type - Global Angina Pectoris Drugs Revenue & Forecasts
4.2.1 By Type - Global Angina Pectoris Drugs Revenue, 2016-2021
4.2.2 By Type - Global Angina Pectoris Drugs Revenue, 2022-2027
4.2.3 By Type - Global Angina Pectoris Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Angina Pectoris Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 ASCs
5.2 By Application - Global Angina Pectoris Drugs Revenue & Forecasts
5.2.1 By Application - Global Angina Pectoris Drugs Revenue, 2016-2021
5.2.2 By Application - Global Angina Pectoris Drugs Revenue, 2022-2027
5.2.3 By Application - Global Angina Pectoris Drugs Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Angina Pectoris Drugs Market Size, 2021 & 2027
6.2 By Region - Global Angina Pectoris Drugs Revenue & Forecasts
6.2.1 By Region - Global Angina Pectoris Drugs Revenue, 2016-2021
6.2.2 By Region - Global Angina Pectoris Drugs Revenue, 2022-2027
6.2.3 By Region - Global Angina Pectoris Drugs Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Angina Pectoris Drugs Revenue, 2016-2027
6.3.2 US Angina Pectoris Drugs Market Size, 2016-2027
6.3.3 Canada Angina Pectoris Drugs Market Size, 2016-2027
6.3.4 Mexico Angina Pectoris Drugs Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Angina Pectoris Drugs Revenue, 2016-2027
6.4.2 Germany Angina Pectoris Drugs Market Size, 2016-2027
6.4.3 France Angina Pectoris Drugs Market Size, 2016-2027
6.4.4 U.K. Angina Pectoris Drugs Market Size, 2016-2027
6.4.5 Italy Angina Pectoris Drugs Market Size, 2016-2027
6.4.6 Russia Angina Pectoris Drugs Market Size, 2016-2027
6.4.7 Nordic Countries Angina Pectoris Drugs Market Size, 2016-2027
6.4.8 Benelux Angina Pectoris Drugs Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Angina Pectoris Drugs Revenue, 2016-2027
6.5.2 China Angina Pectoris Drugs Market Size, 2016-2027
6.5.3 Japan Angina Pectoris Drugs Market Size, 2016-2027
6.5.4 South Korea Angina Pectoris Drugs Market Size, 2016-2027
6.5.5 Southeast Asia Angina Pectoris Drugs Market Size, 2016-2027
6.5.6 India Angina Pectoris Drugs Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Angina Pectoris Drugs Revenue, 2016-2027
6.6.2 Brazil Angina Pectoris Drugs Market Size, 2016-2027
6.6.3 Argentina Angina Pectoris Drugs Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Angina Pectoris Drugs Revenue, 2016-2027
6.7.2 Turkey Angina Pectoris Drugs Market Size, 2016-2027
6.7.3 Israel Angina Pectoris Drugs Market Size, 2016-2027
6.7.4 Saudi Arabia Angina Pectoris Drugs Market Size, 2016-2027
6.7.5 UAE Angina Pectoris Drugs Market Size, 2016-2027
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Angina Pectoris Drugs Major Product Offerings
7.1.4 Pfizer Angina Pectoris Drugs Revenue in Global (2016-2021)
7.1.5 Pfizer Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Angina Pectoris Drugs Major Product Offerings
7.2.4 Bayer Angina Pectoris Drugs Revenue in Global (2016-2021)
7.2.5 Bayer Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Angina Pectoris Drugs Major Product Offerings
7.3.4 AstraZeneca Angina Pectoris Drugs Revenue in Global (2016-2021)
7.3.5 AstraZeneca Key News
7.4 Gilead
7.4.1 Gilead Corporate Summary
7.4.2 Gilead Business Overview
7.4.3 Gilead Angina Pectoris Drugs Major Product Offerings
7.4.4 Gilead Angina Pectoris Drugs Revenue in Global (2016-2021)
7.4.5 Gilead Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Angina Pectoris Drugs Major Product Offerings
7.5.4 Novartis Angina Pectoris Drugs Revenue in Global (2016-2021)
7.5.5 Novartis Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Angina Pectoris Drugs Major Product Offerings
7.6.4 GlaxoSmithKline Angina Pectoris Drugs Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Angina Pectoris Drugs Major Product Offerings
7.4.4 Merck Angina Pectoris Drugs Revenue in Global (2016-2021)
7.7.5 Merck Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Angina Pectoris Drugs Major Product Offerings
7.8.4 Mylan Angina Pectoris Drugs Revenue in Global (2016-2021)
7.8.5 Mylan Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Angina Pectoris Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Angina Pectoris Drugs Revenue in Global (2016-2021)
7.9.5 Teva Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Angina Pectoris Drugs Market Opportunities & Trends in Global Market
Table 2. Angina Pectoris Drugs Market Drivers in Global Market
Table 3. Angina Pectoris Drugs Market Restraints in Global Market
Table 4. Key Players of Angina Pectoris Drugs in Global Market
Table 5. Top Angina Pectoris Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Angina Pectoris Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Angina Pectoris Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Angina Pectoris Drugs Product Type
Table 9. List of Global Tier 1 Angina Pectoris Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angina Pectoris Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type